Literature DB >> 11420451

The origins of informed consent: the International Scientific Commission on Medical War Crimes, and the Nuremburg code.

P Weindling1.   

Abstract

The Nuremberg Code has generally been seen as arising from the Nuremberg Medical Trial. This paper examines developments prior to the Trial, involving the physiologist Andrew Conway Ivy and an inter-Allied Scientific Commission on Medical War Crimes. The paper traces the formulation of the concept of a medical war crime by the physiologist John West Thompson, as part of the background to Ivy's code on human experiments of 1 August 1946. It evaluates subsequent responses by the American Medical Association, and by other war crimes experts, notably Leo Alexander, who developed Ivy's conceptual framework. Ivy's interaction with the judges at Nuremberg alerted them to the importance of formulating ethical guidelines for clinical research.

Entities:  

Keywords:  Biomedical and Behavioral Research; Nuremberg Code; Nuremberg Trials; War and Human Rights Abuses

Mesh:

Year:  2001        PMID: 11420451     DOI: 10.1353/bhm.2001.0049

Source DB:  PubMed          Journal:  Bull Hist Med        ISSN: 0007-5140            Impact factor:   1.314


  19 in total

1.  Medical Ethics in the 70 Years after the Nuremberg Code, 1947 to the Present.

Authors:  Herwig Czech; Christiane Druml; Paul Weindling
Journal:  Wien Klin Wochenschr       Date:  2018-06       Impact factor: 1.704

2.  Reality and revisionism: new evidence for Andrew C Ivy's claim to authorship of the Nuremberg Code.

Authors:  Allan Gaw
Journal:  J R Soc Med       Date:  2014-02-24       Impact factor: 5.344

3.  Racial/Ethnic Differences in Comprehension of Biospecimen Collection: a Nationwide University of Rochester Cancer Center NCI Community Oncology Research Program Study.

Authors:  Matthew Asare; Charles E Heckler; Eva Culakova; Charles S Kamen; Amber S Kleckner; Lori M Minasian; David S Wendler; Michelle Feige; Carol J Weil; Joan Long; Sharon K Cole; Adedayo A Onitilo; Luke J Peppone; Gary R Morrow; Michelle C Janelsins
Journal:  J Cancer Educ       Date:  2020-04       Impact factor: 2.037

4.  Protecting the Vulnerable.

Authors:  Alexander R Hover
Journal:  Mo Med       Date:  2022 May-Jun

5.  Patients' perception of the informed consent process for neurooncology clinical trials.

Authors:  Eva Knifed; Nir Lipsman; Warren Mason; Mark Bernstein
Journal:  Neuro Oncol       Date:  2008-04-03       Impact factor: 12.300

Review 6.  Uncertainty in the translation of preclinical experiments to clinical trials. Why do most phase III clinical trials fail?

Authors:  Pedro R Lowenstein; Maria G Castro
Journal:  Curr Gene Ther       Date:  2009-10       Impact factor: 4.391

7.  Repositioning the patient: patient organizations, consumerism, and autonomy in Britain during the 1960s and 1970s.

Authors:  Alex Mold
Journal:  Bull Hist Med       Date:  2013       Impact factor: 1.314

8.  Procedure versus process: ethical paradigms and the conduct of qualitative research.

Authors:  Kristian Pollock
Journal:  BMC Med Ethics       Date:  2012-09-27       Impact factor: 2.652

9.  Choice is not the issue. The misrepresentation of healthcare in bioethical discourse.

Authors:  Kari Milch Agledahl; Reidun Førde; Age Wifstad
Journal:  J Med Ethics       Date:  2010-12-03       Impact factor: 2.903

10.  Can obtaining informed consent alter self-reported drinking behaviour? A methodological experiment.

Authors:  Lambert Felix; Patrick Keating; Jim McCambridge
Journal:  BMC Med Res Methodol       Date:  2015-04-24       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.